NOMID is the most severe clinical phenotype of a disease spectrum caused by gain-of-function mutations in NLRP3, called the Cryopyrin Associated Periodic Syndromes (CAPS). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.